Elixirr International (ELIX) H1 2026 earnings summary

Executive summary

• Achieved record H1 2026 results with 25% revenue growth to £89.0m and 29% adjusted EBITDA growth to £27.6m, reflecting successful diversification, scaling, and high-quality growth focus.

• AI-related revenue surged 185% year-on-year, reaching £19m, highlighting rapid expansion and strong demand for technology and transformation services.

• Expanded global footprint and capabilities through the acquisition of Kvadrant Consulting, establishing a presence in the Nordics, and strengthened leadership with new senior hires.

• Deepened client relationships, with 35 accounts generating over £1m and 24 accounts over £2m in revenue, both up significantly year-on-year.

• Recognized as a market leader by Forbes and Financial Times, with multiple industry awards and strengthened Board through new Independent Non-Executive Director appointments.

Financial highlights

• Revenue for H1 2026 was £89.0 million, up 25% year-on-year; gross profit increased 26% to £30.6m at a 34% margin.

• Adjusted EBITDA reached £27.6 million, up 29%, with a 31% EBITDA margin, up one percentage point.

• Adjusted profit before tax increased 25% to £25.1 million; adjusted diluted EPS rose 18% to 34.2p.

• Free cash flow was £1.8 million, impacted by seasonality and acquisition-related factors; net debt closed at £56.5 million, primarily due to recent acquisitions.

• Revenue CAGR (2020-2025) was 38%; EBITDA CAGR was 35%; average EBITDA margin was 30%.

Outlook and guidance

• Board expects FY26 adjusted EBITDA and revenue to be in line with market expectations.

• Four-pillar growth strategy continues: organic growth, deepening client relationships, selective M&A, and sustaining premium margins.

• AI and technology-led demand expected to drive further growth as clients move to scaled deployment.

• Ongoing focus on closing the valuation gap and leveraging AI for structural competitive advantage.

• Scalable, diversified business model and focus on higher margin work underpin confidence in future growth.